Wockhardt Limited (WOCKPHARMA.NS)
INR 1453.5
(0.53%)
INR 1453.5
(0.53%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 27.89 Billion | 26.51 Billion | 32.1 Billion | 26.99 Billion | 28.33 Billion | 41.39 Billion |
| Cost of Revenue | 20.17 Billion | 11.11 Billion | 12.67 Billion | 11.35 Billion | 12.03 Billion | 18.14 Billion |
| Gross Profit | 7.72 Billion | 15.4 Billion | 19.43 Billion | 15.63 Billion | 16.29 Billion | 23.25 Billion |
| Operating Expenses | 8.48 Billion | 16.9 Billion | 18.92 Billion | 18.44 Billion | 17.55 Billion | 23.56 Billion |
| Selling, General and Administrative Expenses | 8.34 Billion | 2.44 Billion | 3.28 Billion | 2.66 Billion | 2.43 Billion | 4.62 Billion |
| Research and Development Expenses | 1.32 Billion | 1.41 Billion | 1.43 Billion | 1.72 Billion | 2.08 Billion | 2.9 Billion |
| Other Expenses | -140 Million | 14.46 Billion | 15.64 Billion | 15.77 Billion | 15.12 Billion | 24.2 Million |
| Cost and Expenses | 28.65 Billion | 28.01 Billion | 31.59 Billion | 29.8 Billion | 29.59 Billion | 41.71 Billion |
| Operating Income | 140 Million | -280 Million | 540 Million | -2.66 Billion | -931.7 Million | -310.9 Million |
| Interest Expense | 3.05 Billion | 3.02 Billion | 2.82 Billion | 2.43 Billion | 2.69 Billion | 2.6 Billion |
| Income Tax Expense | 520 Million | -30 Million | -1.32 Billion | -2.71 Billion | -2.04 Billion | -836.6 Million |
| Earnings before Tax | -4.2 Billion | -6.24 Billion | -4.11 Billion | -5.68 Billion | -3.42 Billion | -3 Billion |
| Net Income | -4.63 Billion | -6.21 Billion | -2.79 Billion | -2.96 Billion | -1.37 Billion | -1.94 Billion |
| Earnings Per Share Basic | -32.05 | -43.11 | -23.14 | -24.69 | -11.48 | -16.20 |
| Earnings Per Share Diluted | -32.10 | -43.11 | -23.14 | -24.69 | -11.48 | -16.12 |
| Weighted Average Shares Outstanding | 144.46 Million | 144.06 Million | 120.56 Million | 120.18 Million | 120.14 Million | 120.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 144.25 Million | 144.06 Million | 120.56 Million | 120.18 Million | 120.14 Million | 120.71 Million |
| Gross Margin | 0.28 | 0.58 | 0.61 | 0.58 | 0.58 | 0.56 |
| EBIT Margin | 0.04 | 0.08 | 0.09 | -0.01 | 0.05 | 0.03 |
| Profit Margin | -0.17 | -0.23 | -0.09 | -0.11 | -0.05 | -0.05 |
| EBITDA | 1.08 Billion | -710 Million | 1.35 Billion | -733.8 Million | 1.57 Billion | -201.7 Million |
| Earnings Before Tax Margin | 0.01 | -0.01 | 0.02 | -0.10 | -0.03 | -0.01 |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 7.39 Billion | 27.98 Billion | 7 Billion | 7.01 Billion | 7.53 Billion | 6.44 Billion |
| Cost of Revenue | 5.27 Billion | 20.17 Billion | 5.09 Billion | 3.02 Billion | 2.87 Billion | 2.82 Billion |
| Gross Profit | 2.12 Billion | 7.81 Billion | 1.91 Billion | 3.99 Billion | 4.66 Billion | 3.62 Billion |
| Operating Expenses | 1.74 Billion | 8.48 Billion | 2.29 Billion | 4.02 Billion | 4.49 Billion | 3.99 Billion |
| Selling, General and Administrative Expenses | 1.74 Billion | - | 2.29 Billion | 1.65 Billion | 1.94 Billion | 1.54 Billion |
| Research and Development Expenses | - | - | 1.32 Billion | 300 Million | 340 Million | 360 Million |
| Other Expenses | 300 Million | -140 Million | 520 Million | 80 Million | 240 Million | 140 Million |
| Cost and Expenses | 7.01 Billion | 28.65 Billion | 7.38 Billion | 7.04 Billion | 7.36 Billion | 6.81 Billion |
| Operating Income | 380 Million | -670 Million | -380 Million | -100 Million | 410 Million | -250 Million |
| Interest Expense | 730 Million | 3.05 Billion | 730 Million | 770 Million | 760 Million | 790 Million |
| Income Tax Expense | 100 Million | 520 Million | -30 Million | -10 Million | 380 Million | 180 Million |
| Earnings before Tax | -60 Million | -4.2 Billion | -1.8 Billion | -870 Million | -350 Million | -1.18 Billion |
| Net Income | -140 Million | -4.63 Billion | -1.69 Billion | -830 Million | -770 Million | -1.34 Billion |
| Earnings Per Share Basic | -0.91 | - | -11.73 | -5.76 | -5.34 | -9.30 |
| Earnings Per Share Diluted | -0.91 | - | -11.73 | -5.76 | -5.34 | -9.30 |
| Weighted Average Shares Outstanding | 153.4 Million | 144.46 Million | 144.1 Million | 144.1 Million | 144.09 Million | 144.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 153.4 Million | 144.46 Million | 144.1 Million | 144.1 Million | 144.09 Million | 144.09 Million |
| Gross Margin | 0.29 | 0.28 | 0.27 | 0.57 | 0.62 | 0.56 |
| EBIT Margin | 0.12 | - | 0.03 | 0.06 | 0.13 | 0.05 |
| Profit Margin | -0.02 | -0.17 | -0.24 | -0.12 | -0.10 | -0.21 |
| EBITDA | 920 Million | - | 200 Million | 450 Million | 960 Million | 300 Million |
| Earnings Before Tax Margin | 0.05 | -0.02 | -0.05 | -0.01 | 0.05 | -0.04 |
ASBFY
PEB
STMGF
HUHTAMAKI
FCU
CLHLF